Core Insights - The Pennant Group, Inc. reported quarterly earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.29 per share, and showing an increase from $0.26 per share a year ago, resulting in an earnings surprise of +3.45% [1] - The company achieved revenues of $229.04 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.71% and up from $180.69 million year-over-year [2] - The stock has underperformed the market, losing about 4.7% since the beginning of the year compared to the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $273.5 million, and for the current fiscal year, it is $1.14 on revenues of $925.9 million [7] - The estimate revisions trend for The Pennant Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which The Pennant Group belongs, is currently in the top 18% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - Senseonics Holdings reported a quarterly loss of $0.43 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.33, representing an earnings surprise of -30.30% [1] - The company posted revenues of $8.1 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 1.79%, and showing a significant increase from $4.26 million in the same quarter last year [2] - Senseonics has surpassed consensus revenue estimates three times over the last four quarters, but has only exceeded EPS estimates once in the same period [2] 分组2 - The stock has underperformed, losing approximately 36.1% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.32 on revenues of $15.05 million, and for the current fiscal year, it is -$1.40 on revenues of $35.91 million [7] - The Zacks Industry Rank for Medical Info Systems is in the top 26% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Insights - EnerSys reported quarterly earnings of $2.56 per share, exceeding the Zacks Consensus Estimate of $2.36 per share, and showing an increase from $2.12 per share a year ago, representing an earnings surprise of +8.47% [1] - The company achieved revenues of $951.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 7.10% and up from $883.7 million year-over-year [2] - EnerSys shares have increased by approximately 33.2% since the beginning of the year, outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.53, with expected revenues of $927.95 million, and for the current fiscal year, the EPS estimate is $9.76 on revenues of $3.69 billion [7] - The estimate revisions trend for EnerSys was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Manufacturing - Electronics industry, to which EnerSys belongs, is currently ranked in the top 17% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - electroCore, Inc. reported a quarterly loss of $0.4 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.36, and compared to a loss of $0.31 per share a year ago, indicating an earnings surprise of -11.11% [1] - The company posted revenues of $8.69 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 10.69%, and showing an increase from $6.55 million in the same quarter last year [2] - electroCore shares have declined approximately 69.5% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.26 on revenues of $8.89 million, and for the current fiscal year, it is -$1.59 on revenues of $30.84 million [7] - The Zacks Industry Rank for Medical - Drugs is currently in the top 40% of over 250 Zacks industries, suggesting that the industry outlook can significantly impact stock performance [8]

分组1 - Guild Holdings Company (GHLD) reported quarterly earnings of $0.75 per share, exceeding the Zacks Consensus Estimate of $0.51 per share, and showing an increase from $0.51 per share a year ago, resulting in an earnings surprise of +47.06% [1] - The company achieved revenues of $307.44 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.61%, and significantly up from $159.26 million in the same quarter last year [2] - Guild has outperformed the S&P 500, with shares increasing about 40.9% since the beginning of the year compared to the S&P 500's gain of 15.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.36 on revenues of $289.99 million, and for the current fiscal year, it is $1.88 on revenues of $1.06 billion [7] - The Zacks Industry Rank for Financial - Miscellaneous Services is in the top 31% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] 分组3 - The estimate revisions trend for Guild was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

ACV Auctions Inc. (ACVA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.07 per share when it actually produced earnings of $0.07, delivering no surprise.Over the last four quarters, the company has surpassed consensus EPS estimates just once.ACV Auctions, which belongs to the Z ...

Core Insights - Pulse Biosciences reported a quarterly loss of $0.29 per share, which was better than the Zacks Consensus Estimate of a loss of $0.31, but worse than a loss of $0.16 per share a year ago, indicating an earnings surprise of +6.45% [1] - The company generated revenues of $0.09 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 82.8%, compared to zero revenues a year ago [2] - The stock has underperformed, losing about 7.8% since the beginning of the year, while the S&P 500 gained 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.33 on revenues of $0.75 million, and for the current fiscal year, it is -$1.17 on revenues of $1.25 million [7] - The estimate revisions trend for Pulse Biosciences was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical - Instruments industry, to which Pulse Biosciences belongs, is currently in the top 37% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, Teleflex, is expected to report quarterly earnings of $3.38 per share, reflecting a year-over-year change of -3.2%, with revenues expected to be $893.51 million, up 16.9% from the previous year [9][10]

Core Insights - Penumbra reported quarterly earnings of $0.97 per share, exceeding the Zacks Consensus Estimate of $0.90 per share, and showing an increase from $0.85 per share a year ago, resulting in an earnings surprise of +7.78% [1] - The company achieved revenues of $354.69 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.12% and up from $301.04 million year-over-year [2] - Penumbra has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Company Performance - The stock has underperformed the market, losing about 1% since the beginning of the year, while the S&P 500 gained 15.1% [3] - The current consensus EPS estimate for the upcoming quarter is $1.10 on revenues of $361.16 million, and for the current fiscal year, it is $3.68 on revenues of $1.37 billion [7] - The estimate revisions trend for Penumbra was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which Penumbra belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment and stock performance [5]

Grand Canyon Education (LOPE) came out with quarterly earnings of $1.78 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.48 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this for-profit education company would post earnings of $1.37 per share when it actually produced earnings of $1.53, delivering a surprise of +11.68%.Over the last four quarters, the company has surpassed consensus EPS estimates three time ...

Fair Isaac (FICO) came out with quarterly earnings of $7.74 per share, beating the Zacks Consensus Estimate of $7.34 per share. This compares to earnings of $6.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.45%. A quarter ago, it was expected that this financial services company would post earnings of $7.73 per share when it actually produced earnings of $8.57, delivering a surprise of +10.87%.Over the last four quarter ...